SPX 0.02% VIX 2.34%
DOW, NASDAQ POST RECORD CLOSE AS STOCKS EDGE HIGHER 
STOCKS UNDER INCREASING PRESSURE MONDAY AS SECOND-QUARTER EARNINGS SEASON OPENS 
SYMANTEC SHARES PLUNGE ON REPORTED HALT IN BROADCOM DEAL TALKS 
NEW YORK FED'S MANUFACTURING GAUGE SHOWS JULY REBOUND 
NEED TO KNOW: HOW STOCK-MARKET INVESTMENTS ARE LIKE FYRE FESTIVAL TICKETS 
CITI SHARES UP IN PREMARKET AFTER SALES AND PROFIT RISE 
CALLON PETROLEUM SAYS IT WILL BUY CARRIZO OIL & GAS FOR $3.2 BILLION 
U.S. STOCKS END AT RECORD HIGHS, FUELED BY OPTIMISM OVER FED INTEREST-RATE CUTS 
FACEBOOK STOCK MOVES HIGHER AFTER REPORT OF $5 BILLION FTC SETTLEMENT 
THERE ARE 5 THINGS ATOP INVESTORS' MINDS AS EARNINGS SEASON IS ABOUT TO BEGIN 
Mon, Jul 15 7:05pm

Compare TYME



Tyme Technologies, Inc. - Common Stock [TYME]
$1.25 0.00 (0.00%)

TYME Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 140 Million
TYME Description

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.


Visit Website

TYME Earnings

EPS -0.11 P/E Ratio 0.00
Previous Earnings Mon, Nov 5, 2018
Latest Earnings Wed, May 29, 2019 (47 days ago) -3.85%

TYME Dividend

Yield --
Ex-Date --
Pay Date --
History --

TYME Charts

$0.92
52 Week Range
$4.25
Jun 20, 2019
Dec 12, 2018



Symbol Price Day % YTD %
TYME $1.25 0.00% -63.02%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy